Original Articles (2011-2015)

  1. Kawaguchi M, Kanemaru A, Fukushima T, Yamamoto K, Tanaka H, Haruyama Y, Itoh H, Matsumoto N, Kangawa K, Nakazato M, Kataoka H.Ghrelin administration suppresses inflammation]associated colorectal carcinogenesis in mice. Cancer Sci. , 106:1130-1136 (2015)
  2. Haruyama Y, Yorita K, Yamaguchi T, Kitajima S, Amano J, Ohtomo T, Ohno A, Kondo K, Kataoka H.High pre-operative levels of serum N-terminal subunit of glypican 3 are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy. Int. J. Cancer, 137: 1643-1651 (2015)
  3. Mukai S, Yorita K, Yamasaki K, Nagai T, Kamibeppu T, Sugie S, Kida K, Onizuka C, Tsukino H, Kamimura T, Kamoto T, Kataoka H.Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis. Hum. Cell, 28: 133-142 (2015)
  4. Kawaguchi M, Kanemaru A, Sawaguchi A, Yamamoto K, Baba T, Lin C-Y, Johnson MD, Fukushima T, Kataoka H.Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling. Am. J. Pathol., 185:1610-1623 (2015)
  5. Kawasoe T, Takeshima H, Yamashita S, Mizuguchi S, Fukushima T, Yokogami K, Yamasaki K. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. J Neurosurg, 122:317-323 (2015), DOI:10.3171/2014.10.JNS132159.
  6. Satoh K, Nimura S, Hamasaki M, Aoki M, Koga K, Iwasaki H, Yamashita Y, Kataoka H, Nabeshima K. Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: Possible involvement of c-Met. Cancer Sci. , 105:1487-1495 (2014)
  7. Mukai S, Yorita K, Kawagoe Y, Katayama Y, Nakahara K, Kamibeppu T, Sugie S, Tukino H, Kamoto T, Kataoka H. Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis. Hum. Cell, 28:44-50 (2015)
  8. Friis S, Sales KU, Schafer JM, Vogel LK, Kataoka H, Bugge TH. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. J. Biol. Chem., 289:22319-22332 (2014)
  9. Matafonov A, Leung PY, Gailani AE, Grach SL, Cheng Q, Sun M, McCarty OJT, Tucker EI, Kataoka H, Renne T, Morrissey JH, Gruber A, Gailani D. Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood, 123:1739-1746 (2014), DOI:10.1182/blood-2013-04-499111.
  10. Ohno A, Yorita K, Haruyama Y, Kondo K, Kato A, Ohtomo T, Kawaguchi M, Marutuska K, Chijiiwa K, Kataoka H. Aberrant expression of monocarbohydrate transporter 4 (MCT4) in tumor cells predicts an unfavorable outcome in patients with hepatocellular carcinoma. Liver Int., 34:942-952 (2014)
  11. Takahashi N, Fumiyo Aoyama F, Hiyoshi M, Kataoka H, Sawaguchi A. Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater. Int. J. Oncol., 44:1139-45 (2014)
  12. Ishida Y, Yamasaki M, Yukizaki C, Nishiyama K, Tsubouchi H, Okayama A, Kataoka H. Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion; proteomic approach using fluorescent two-dimensional differential gel electrophoresis. Hum. Cell, 27:68-77 (2014)
  13. Ye J, Kawaguchi M, Haruyama Y, Kanemaru A, Fukushima T, Yamamoto K, Lin CY, Kataoka H. Loss of HAI-1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model. Cancer Sci., 105;44-51 (2014)
  14. Wu B-Y, Lee S-P, Hsiao H-C, Chiu H, Chen C-Y, Yeo YH, Lee H-S, Chen Y-W, Kaul M, Kataoka H, Johnson M, Wang J-K, Lin C-Y. Matriptase expression and zymogen activation in human pilosebaceous unit. J. Histochem. Cytochem., 62:50-9 (2014)
  15. Kai H, Akamatsu E, Torii E, Kodama H, Yukizaki C, Akagi I, Ino H, Sakakibara Y, Suiko M, Yamamoto I, Okayama A, Morishita K, Kataoka H, Matsuno K: Identification of a Bioactive Compound against Adult T-cell Leukaemia from Bitter Gourd Seeds. Plants, 3, 18-26 (2014)
  16. Koga K, Hamsakia M, Kato F, Aoki M, Hayashi H, Iwasaki A, Kataoka H, Nabeshima K. Association of c-Met phosphorylation with micropapillary pattern and small cluster invasion in pT1-size lung adenocarcinoma. Lung Cancer, 82: 413-419 (2013)
  17. Chou FP, Chen YW, Zhao XF, Xu-Monette ZY, Young KH, Gartenhaus RB, Wang JK, Kataoka H, Annie H. ZuoAH, Johnson M, Lin CY. Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas. Am. J. Pathol., 183: 1306-1317 (2013)
  18. Chen YW, Xu ZH, Baksh ANH, Wang JK, Chen CY, Swanson R, Olson ST, Kataoka H, Johnson MD, Lin CY. Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes. PLoS ONE, 8(5): e62826. doi:10.1371/journal.pone.0062826 (2013)
  19. Hoshiko S, Kawaguchi M, Fukushima T, Haruyama Y, Yorita Y, Tanaka H, Seiki M, Inatsu H, Kitamura K, Kataoka H. Hepatocyte growth factor activator inhibitor type 1 (Hai-1/Spint1) is a suppressor of intestinal tumorigenesis. Cancer Res., 73:2659-2670 (2013)
  20. Koivuniemi R, Makela J, Hokkanen ME, Bruelle C, Ho TH, Ola R, Korhonen L, Schroder J, Kataoka H, Lindholm D. Hepatocyte growth factor activator inhibitor-1 is induced by bone morphogenetic proteins and regulates proliferation and cell fate of neural progenitor cells. PLoS ONE, 8(2):e56117. doi: 10.1371/journal.pone.0056117 (2013)
  21. Kohama K, Kawaguchi M, Fukushima T, Lin C-Y, Kataoka H. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells. Hum. Cell, 25:100-110 (2013)
  22. Yuji K, Sakaida H, Kai T, Fukuda N, Yukizaki C, Sakai M, Tsubouchi H, Kataoka H. Effect of dietary blueberry (Vaccinium ashei reade) leaf on serum and hepatic lipids in rats. J. Oleo. Sci., 62:89-96 (2013)
  23. Yamagata Y, Aikou S, Fukushima T, Kataoka H, Seto Y, Esumi H, Kaminishi M, James R Goldenring JR, Nomura S. Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels. Am. J. Physiol.-Gastroint. Liver Physiol., 303:G1254-1261 (2012)
  24. Baba T, Kawaguchi M, Fukushima T, Sato Y, Orikawa H,Yorita K,Tanaka H, Lin C-Y, Sakoda S, Kataoka H. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells invasiveness. J. Pathol., 228:181-192 (2012)
  25. Matsubara D, Kanai Y, Ishikawa S, Ohara S, Yoshimoto T, Sakatani T, Oguni S, Tamura T, Kataoka H, Endo S, Murakami Y, Aburatani H, Fukayama M, Niki T. Identification of CCDC6-RET fusion in a human lung adenocarcinoma cell line, LC-2/ad. J. Thorac. Oncol., 7:1872-6 (2012)
  26. Orikawa H, Kawaguchi M, Baba T, Yorita K, Sakoda S, Kataoka H.Activation of macrophage-stimulating protein by human airway trypsin-like protease. FEBS Lett. , 586:217-221 (2012)
  27. Kato M, Hashimoto T, Kataoka H, Shimomura T, Kitamura N. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease. J. Biochem., 151:179-187 (2012)
  28. Xu H, Xu, Z, Tseng I-C, Chou F-P, Chen Y-W, Wang J-K, Johnson M, Kataoka H, C-Y Lin. Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1. Am. J. Physiol-Cell Physiol., 302:C453-462 (2012)
  29. Fukushima T, Kawaguchi M, Yorita K, Tanaka H, Umezawa K, Takeshima H, Kataoka H. Antitumor effect of dehydroxymethylepoxyquinomicin (DHMEQ), a small molecule inhibitor of nuclear factor-kB, on glioblastoma. Neuro. Oncol., 14:19-28 (2012)
  30. Kai H, Akamatsu E, Torii E, Kodama H, Yukizaki C, Sakakibara Y, Suiko M, Morishita K, Kataoka H, Matsuno K. Inhibition of leukaemia cell proliferation by agricultural plant extracts in seven human adult T-cell leukaemia (ATL)-related human leukaemia cell lines. J. Nat. Med., 65: 651-655 (2011)
  31. Kawaguchi M, Takeda N, Hoshiko S, Yorita K, Baba T, Sawaguchi A, Nezu Y, Yoshikawa T, Fukushima T, Kataoka H. Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity. Am. J. Pathol., 179:1815-1826 (2011)
  32. Yorita K, Takahashi N, Takai H, Kato A, Suzuki M, Ishiguro T, Ohtomo T, Nagaike K, Kondo K, Chijiiwa K, Kataoka H. Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma. Liver Int., 31:120-31 (2011)
  33. Fukushima T, Kawaguchi M, Yamasaki M, Tanaka H, Yorita K, Kataoka H. Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells. Cancer Sci., 102:407-413 (2011)